Perrigo Company

Nov 19, 09
	NEW STORY
10:00 ET	Perrigo Company To Present at the Sidoti Emerging Growth Conference
Nov 09, 09
10:45 ET	Perrigo Company to Present at the Credit Suisse 18th Annual Health Care Conference
Nov 02, 09
07:30 ET	Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance
07:00 ET	Perrigo Company Divests Israel Cosmetics Business for 205 Million New Israeli Shekels
Oct 29, 09
12:07 ET	Perrigo Company Announces Dividend Increase
Oct 19, 09
12:30 ET	Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
09:05 ET	Perrigo Announces Dismissal of Duac(R) Patent Litigation
Oct 13, 09
09:20 ET	Perrigo Confirms Filing for Generic Version of Men's Rogaine(R) Foam
Oct 06, 09
16:08 ET	Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
Sep 21, 09
13:44 ET	Perrigo Company To Host Investor Day
08:13 ET	Perrigo Acquires ANDA for Generic Version Duac(R) Gel From KV Pharmaceutical
Aug 18, 09
07:57 ET	Perrigo Reports Record Sales, Earnings and Cash Flow From Operations for Fiscal 2009
Aug 13, 09
09:26 ET	Perrigo Company Announces Quarterly Dividend
Aug 04, 09
16:20 ET	Perrigo Company Will Release Fiscal Year 2009 Results on August 18, 2009
Aug 03, 09
12:53 ET	Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
Jul 13, 09
09:44 ET	Perrigo Receives FDA Approval to Market Cherry and Cinnamon Flavored Nicotine Lozenges
Jun 24, 09
10:29 ET	Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal(R) Solution and Announcement of Lawsuit by Sepracor/UCB
May 07, 09
07:45 ET	Perrigo Reports Record Third Quarter
May 06, 09
10:10 ET	Perrigo Company Announces Quarterly Dividend
Mar 24, 09
16:06 ET	Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
Mar 17, 09
08:28 ET	Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
Feb 20, 09
07:48 ET	Perrigo Begins Shipments of Ibuprofen PM
Feb 03, 09
07:51 ET	Perrigo Reports Record Second Quarter Sales
Jan 28, 09
08:40 ET	Perrigo Company Announces Quarterly Dividend
Jan 21, 09
10:10 ET	Perrigo Company Will Release Second Quarter Fiscal Year 2009 Results on February 3, 2009
Jan 07, 09
08:31 ET	Perrigo Company to Present at the 27th Annual JPMorgan Healthcare Conference
Dec 29, 08
10:01 ET	Perrigo Announces FDA Final Approval for Ibuprofen PM
Dec 04, 08
08:49 ET	Perrigo Settles Desloratadine Patent Litigation
Nov 19, 08
08:00 ET	Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation
Nov 13, 08
08:00 ET	Perrigo Acquires Unico Holdings
Nov 06, 08
08:10 ET	Perrigo Reports Record First Quarter Sales and Income
Nov 04, 08
12:03 ET	Perrigo Company Announces Dividend Increase
Oct 29, 08
08:56 ET	Perrigo Announces FDA Tentative Approval for Ibuprofen PM
Oct 23, 08
11:00 ET	Perrigo Company will Release First Quarter Fiscal Year 2009 Results on November 6, 2008
Oct 06, 08
07:49 ET	Perrigo Acquires Mexican Manufacturer Laboratorios Diba, S.A.
Oct 03, 08
08:14 ET	Perrigo Company to Present at the JMP Securities 2008 Healthcare Focus Conference
Sep 18, 08
09:10 ET	Perrigo Dismissed from Miconazole Patent Litigation
Sep 16, 08
07:33 ET	Perrigo Acquires JB Laboratories
Sep 15, 08
14:04 ET	Perrigo Company To Present at the Merrill Lynch Global Pharmaceutical Conference
Sep 08, 08
08:00 ET	Perrigo Acquires Exclusive Sales and Distribution Rights to Allergy Drug Levocetirizine from Synthon
Aug 18, 08
08:15 ET	Perrigo Reports Record Sales, Earnings and Cash Flow from Operations for Fiscal 2008
Aug 13, 08
09:30 ET	Perrigo Company Announces Quarterly Dividend
Aug 11, 08
12:04 ET	Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide
Aug 05, 08
11:28 ET	Perrigo Company to Present at the Bank of America Specialty Pharmaceuticals Conference
09:48 ET	Perrigo Company to Present at the Bank of America Specialty Pharmaceuticals Conference
09:47 ET	Perrigo Company Will Release Fiscal Year 2008 Results on August 18, 2008
Jul 15, 08
12:20 ET	Perrigo to Grow in Michigan
Jul 11, 08
08:00 ET	Perrigo Company Announces Appointment of New Board Member
Jul 07, 08
16:25 ET	Perrigo Company to Present at The Oppenheimer & Co. Inc. 8th Annual Consumer Growth Conference
Jun 19, 08
08:50 ET	Perrigo Announces Approval for Rx Cetirizine Syrup
Jun 09, 08
15:15 ET	Perrigo Confirms Filing for Generic Version of VANOS(R)
May 21, 08
08:12 ET	Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech
May 20, 08
11:50 ET	Perrigo Company to Present at the Citi Investment Research Global Health Care Conference
May 06, 08
07:16 ET	Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008
May 01, 08
08:36 ET	Perrigo Company Announces Quarterly Dividend
Apr 24, 08
15:02 ET	Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum
Apr 23, 08
13:55 ET	Perrigo Company Will Release Third Quarter Fiscal 2008 Results on May 6, 2008
Apr 21, 08
16:25 ET	Perrigo Confirms Patent Challenge of Monistat(R) 1 Combination Pack
Apr 14, 08
07:57 ET	Perrigo Announces Approval for Over-the-Counter Children's Cetirizine Oral Solution
Mar 24, 08
10:55 ET	Perrigo Company to Present at the 12th Annual Sidoti Emerging Growth Institutional Investor Forum
Mar 20, 08
15:16 ET	Perrigo Company Announces Launch of Clobetasol Propionate Foam
Mar 11, 08
11:06 ET	Perrigo Company Receives Final Approval on Clobetasol Propionate Foam
Mar 06, 08
12:56 ET	Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets
Mar 04, 08
14:26 ET	Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets
Feb 12, 08
13:17 ET	Perrigo Company Announces Final FDA Approval for OTC Famotidine Complete Chewable Tablets
Feb 05, 08
15:39 ET	Perrigo Company to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
08:00 ET	Perrigo Reports Record Sales and Earnings for Second Quarter Fiscal 2008
Feb 01, 08
13:31 ET	Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend
Jan 22, 08
16:00 ET	Perrigo Company will Release Second Quarter Fiscal 2008 Results on February 5, 2008
Jan 09, 08
12:00 ET	Perrigo Acquires UK OTC Store Brand Supplier
Jan 04, 08
16:14 ET	Perrigo Company to Present at The 26th Annual JPMorgan Healthcare Conference
Dec 28, 07
09:22 ET	Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets
Dec 10, 07
16:00 ET	Perrigo Announces Final FDA Approval of Dexcel's OTC Omeprazole; Raises Full Year Earnings Guidance
Nov 01, 07
08:08 ET	Perrigo Reports Record Sales and Income for Fiscal 2008 First Quarter; Increases Full Year Guidance
08:02 ET	Perrigo Announces that Dexcel's Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
Oct 31, 07
10:30 ET	Perrigo Elevates Joseph C. Papa to Chairman of the Board
Oct 30, 07
12:33 ET	Perrigo Company Announces Dividend Increase
Oct 19, 07
13:02 ET	Perrigo Company Will Release First Quarter Fiscal 2008 Results on November 1, 2007
Sep 27, 07
14:37 ET	Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
Sep 19, 07
14:18 ET	Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
Sep 14, 07
17:00 ET	Perrigo Company to Host Analyst Meeting on September 18, 2007
Sep 13, 07
12:00 ET	Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service
Aug 23, 07
08:05 ET	Perrigo Reports Record Sales for Fiscal 2007 Full Year and Fourth Quarter
Aug 16, 07
09:35 ET	Perrigo Company Announces Quarterly Dividend
Aug 09, 07
14:55 ET	Perrigo Company Will Release Fiscal Year 2007 Results on August 23, 2007
Jul 11, 07
08:30 ET	Perrigo Company Completes Qualis Acquisition
Jun 20, 07
12:15 ET	Perrigo Announces Tentative FDA Approval of Dexcel's OTC Omeprazole
Jun 07, 07
09:08 ET	Perrigo Company to Present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference
Jun 06, 07
10:17 ET	Perrigo Wins Famotidine Complete Patent Litigation
May 30, 07
13:30 ET	Perrigo Receives FDA Approval to Market Coated Fruit Nicotine Gum
May 08, 07
08:43 ET	Perrigo Reports Strong Fiscal 2007 Third Quarter Revenue Growth
May 02, 07
10:01 ET	Perrigo Company Announces Quarterly Dividend
May 01, 07
13:55 ET	Perrigo Company to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Apr 27, 07
08:55 ET	Perrigo Company Will Release Third Quarter Fiscal 2007 Results on May 8, 2007
Apr 05, 07
15:15 ET	Perrigo Company to Present at the CIBC World Markets Biotechnology & Pharmaceuticals Conference
Mar 27, 07
08:36 ET	Perrigo Announces Organizational Changes
Mar 07, 07
08:00 ET	Perrigo Company to Acquire Qualis, Inc.
Mar 06, 07
16:27 ET	Perrigo Company to Present at the Citigroup Small and Mid-Cap Conference
08:51 ET	Perrigo Company to Acquire Generic Dermatological Products From Glades Pharmaceuticals
Feb 22, 07
13:45 ET	Perrigo Company Announces Appointment of New Board Member
Feb 08, 07
16:29 ET	Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend
Feb 01, 07
15:58 ET	Perrigo Company to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
07:42 ET	Perrigo Company's Second Quarter Revenue Growth Driven By New Products
Jan 18, 07
09:00 ET	Perrigo Company Will Release Second Quarter Fiscal 2007 Results On February 1, 2007
Jan 04, 07
13:45 ET	Perrigo Company to Present at the 25th Annual JPMorgan Healthcare Conference
Dec 21, 06
11:00 ET	Perrigo Company Announces FDA Approval For Simvastatin Tablets
Dec 19, 06
12:00 ET	Perrigo Company Announces FDA Approval For Ciclopirox Topical Suspension
Dec 18, 06
12:50 ET	Perrigo Announces Issue of Approvable Letter by FDA for Dexcel's OTC Omeprazole
Nov 10, 06
13:00 ET	Perrigo Company Announces Dividend Increase
Nov 09, 06
15:51 ET	Perrigo Launches Precautionary Recall
08:50 ET	Perrigo Announces Voluntary Product Recall and Reaffirms Full Year Earnings
Oct 31, 06
08:30 ET	Perrigo Company's First Quarter Revenue Increases Seven Percent Driven by New Product Growth
Oct 24, 06
08:42 ET	Perrigo Company Will Release First Quarter Fiscal 2007 Results on October 31, 2006
Oct 09, 06
08:34 ET	Joseph C. Papa Is New President and CEO at Perrigo Company
Oct 03, 06
16:08 ET	Perrigo Company Will Host Conference Call Introducing Joe Papa as President and Chief Executive Officer on October 10, 2006
Oct 02, 06
16:41 ET	Perrigo Receives Tentative Approval for Ciclopirox Topical Solution
Sep 25, 06
16:35 ET	Perrigo Announces Approval for Famotidine Tablets
Sep 11, 06
07:30 ET	Perrigo Announces Joseph C. Papa as New CEO; David T. Gibbons to Remain as Chairman
Sep 01, 06
09:15 ET	Perrigo Receives Tentative Approval For Clobetasol Propionate Foam
Aug 11, 06
11:53 ET	Perrigo Company Announces Quarterly Dividend
Aug 09, 06
08:30 ET	Perrigo Company Reports Fiscal Year 2006 Financial Results
Aug 07, 06
08:30 ET	Perrigo Company to Market Terbinafine Hydrochloride Tablets
Aug 01, 06
15:03 ET	Perrigo Company Will Release Fiscal Year 2006 Results on August 9, 2006
Jul 06, 06
16:04 ET	Perrigo Company Announces Judy Brown Assumes CFO Position
Jun 29, 06
16:45 ET	Perrigo Company to Market Amlodipine Besylate Tablets
Jun 27, 06
08:00 ET	Perrigo Company to Close Two Facilities, Employees Offered Opportunity to Transfer
Jun 14, 06
09:03 ET	Perrigo Company Receives FDA Approval to Market Coated Nicotine Gum
Jun 07, 06
08:37 ET	Perrigo Announces Participation in Dexcel's Filing for Generic Version of Prilosec OTC(R)
May 12, 06
13:00 ET	Perrigo Company Announces Quarterly Dividend
May 10, 06
13:50 ET	Perrigo Company to Present at Bank of America 2006 Health Care Conference
May 04, 06
07:35 ET	Perrigo Acknowledges Barr Patent Challenge of NASACORT(R) AQ Nasal Spray
Apr 27, 06
08:30 ET	Perrigo Company Reports Third Quarter Fiscal 2006 Financial Results
Apr 20, 06
09:34 ET	Perrigo Company Will Release Third Quarter Fiscal 2006 Results on April 27, 2006
Apr 11, 06
08:45 ET	Perrigo Company Shareholder Rights Agreement Expires
Mar 21, 06
16:14 ET	Perrigo Company Announces Approval For Terconazole Suppositories
Mar 10, 06
15:03 ET	Perrigo Company to Present at Bank of America 2006 Consumer Conference
Mar 07, 06
16:08 ET	Perrigo Company Announces Approval for Ciclopirox Olamine Cream
Mar 02, 06
16:33 ET	CFO Announces Plans to Retire from Perrigo
Feb 22, 06
08:34 ET	Perrigo Company Announces Tentative Approval for Sertraline Hydrochloride Tablets
Feb 21, 06
15:06 ET	Perrigo Company Announces Appointment of New Board Member
Feb 15, 06
13:19 ET	Perrigo Company Announces Quarterly Dividend
Feb 02, 06
12:37 ET	Perrigo Company Receives FDA Approval to Market Nicotine Lozenges
08:34 ET	Perrigo Company Reports Second Quarter Fiscal 2006 Financial Results
Jan 27, 06
12:39 ET	Perrigo Company Will Release Second Quarter Fiscal 2006 Results on February 2, 2006
Jan 10, 06
16:16 ET	Perrigo Company Announces FDA Approval for Desoximetasone Gel
Oct 28, 05
09:56 ET	Perrigo Company Announces Dividend Increase
Oct 27, 05
08:35 ET	Perrigo Company Reports First Quarter Fiscal 2006 Financial Results
Oct 25, 05
16:19 ET	Perrigo Confirms Patent Challenge of Olux(R) Foam
Oct 20, 05
16:36 ET	SCOLR Pharma and Perrigo Announce Strategic Alliance to Manufacture and Market CDT(R) Nutritional Products
09:39 ET	Perrigo Company Will Release First Quarter Fiscal 2006 Results on October 27, 2005
Oct 07, 05
10:43 ET	Perrigo Company Receives Final Approval For Glimepiride Tablets
Sep 21, 05
08:31 ET	Webcast Alert: Perrigo Company Announces Analysts' Meeting Webcast
Sep 12, 05
16:01 ET	Perrigo Company Announces Tentative Approval for Famotidine Tablets
Sep 07, 05
08:33 ET	Perrigo Company Reports Fiscal Year 2005 Financial Results
Aug 29, 05
16:01 ET	Perrigo Company Will Release Fourth Quarter and Fiscal Year 2005 Results on September 7, 2005
Aug 25, 05
08:30 ET	Perrigo Company Announces Tentative Approval for Glimepiride Tablets
Aug 05, 05
09:32 ET	Perrigo Company Announces Quarterly Dividend
Jul 19, 05
16:09 ET	Perrigo Company Announces Approval For Prescription Strength Ibuprofen Tablets
Jun 24, 05
09:10 ET	Perrigo Company Announces Approval for Orange Ibuprofen Tablets
Jun 16, 05
16:05 ET	Perrigo Company Announces 10b5-1 Plan
May 05, 05
08:59 ET	Perrigo Company Reports Fiscal 2005 Third Quarter and Nine Months Losses Due to Write Off of In-Process Research and Development
Apr 28, 05
16:19 ET	Perrigo Company Announces Approval for Naproxen Tablets
10:19 ET	Perrigo Company Will Release Third Quarter Results For Fiscal 2005 On May 5, 2005
Apr 26, 05
16:11 ET	Perrigo Company Announces $30 Million Share Repurchase Program
Apr 22, 05
09:28 ET	Perrigo Company Announces Quarterly Dividend
Apr 11, 05
11:01 ET	Perrigo Company Announces FDA Approval For Mometasone Furoate Topical Solution
Mar 17, 05
13:35 ET	Perrigo Company Completes Acquisition of Agis Industries
Mar 15, 05
13:08 ET	Perrigo Announces Shareholder Approval of Agis Industries Acquisition
Feb 04, 05
09:34 ET	Perrigo Company Announces Quarterly Dividend
Feb 01, 05
08:34 ET	Perrigo Company Reports Second Quarter Fiscal 2005 Earnings
Jan 28, 05
08:31 ET	Perrigo Company Will Release Second Quarter Results for Fiscal 2005 on February 1, 2005
Nov 03, 04
09:44 ET	Bentley Pharmaceuticals and Perrigo Company Announce Multi-Product Collaboration
Oct 29, 04
08:08 ET	Perrigo Company Announces Dividend Increase of 14 Percent
Oct 26, 04
08:23 ET	Perrigo Company Reports First Quarter Fiscal 2005 Earnings of $0.24 Per Share
Oct 20, 04
09:13 ET	Perrigo Company Will Release First Quarter Results for Fiscal 2005 on October 26, 2004
Oct 05, 04
16:47 ET	Perrigo Company Receives FDA Approval to Market Nicotine Gum and Ibuprofen Oral Suspension
Aug 10, 04
08:32 ET	Perrigo Company Reports Fiscal Year 2004 Earnings of $1.11 Per Share
Aug 06, 04
10:18 ET	Perrigo Company Announces Quarterly Dividend
Aug 04, 04
08:40 ET	Perrigo Company Will Release Fourth Quarter and Year-End Results for Fiscal 2004 August 10, 2004
Aug 03, 04
08:23 ET	Perrigo Negotiating Settlement With FTC
Jul 15, 04
17:04 ET	Perrigo Company to Acquire Certain Assets of APG, Inc.
Jun 10, 04
08:32 ET	Perrigo Company Updates Status of Lannett Company Option
May 06, 04
10:08 ET	Perrigo Company Responds to Lannett Announcement
Apr 30, 04
10:22 ET	Perrigo Company Announces Quarterly Dividend
Apr 23, 04
08:32 ET	Perrigo Company Reports Third Quarter Fiscal 2004 Earnings
Apr 16, 04
08:28 ET	Perrigo Company Will Release Third Quarter Results for Fiscal 2004 on April 23, 2004
Mar 31, 04
12:09 ET	Perrigo Company to Present at Banc of America Securities Consumer Conference
Feb 13, 04
08:00 ET	Perrigo Company Acquires Irrevocable Option to Purchase Controlling Interest in Lannett
Feb 03, 04
09:02 ET	Perrigo Company Reports Record Second Quarter Fiscal 2004 Results
Jan 30, 04
10:01 ET	Perrigo Company Announces Quarterly Dividend
Jan 29, 04
11:28 ET	Perrigo Company Will Release Second Quarter Results For Fiscal 2004 on February 3, 2004
Jan 27, 04
08:31 ET	Perrigo Company Announces Resolution of Federal Tax Examination
Dec 12, 03
08:30 ET	Perrigo Company Acquires Peter Black Pharmaceuticals, Ltd.
Nov 14, 03
18:35 ET	Perrigo Company Announces Approvals to Market Three New Products
18:32 ET	Alpharma, Perrigo Agreement Subject of FTC Inquiry
Oct 29, 03
08:52 ET	Perrigo Company Extends Share Repurchase Program
Oct 28, 03
09:22 ET	Perrigo Company Announces Dividend Increase of 40 Percent
Oct 24, 03
08:32 ET	Perrigo Company Reports First Quarter Fiscal 2004 Earnings of $0.23 Per Share
Oct 21, 03
12:15 ET	Perrigo Company Will Release First Quarter Results for Fiscal 2004 on October 24, 2003
Sep 03, 03
10:00 ET	Perrigo Launches New Branded Dietary Supplement Product
Sep 02, 03
16:34 ET	Former Pfizer Attorney Joins Perrigo Company As Vice President & General Counsel
Aug 11, 03
09:32 ET	Perrigo Company Announces Board of Director Changes
08:31 ET	Perrigo Company Reports Fiscal 2003 Earnings of $0.76 Per Share
Aug 07, 03
11:32 ET	Perrigo Company Will Release Fourth Quarter and Year End Results for Fiscal 2003 on August 11, 2003
09:45 ET	Perrigo Company Declares Quarterly Dividend
May 09, 03
12:41 ET	Perrigo Company Declares Quarterly Dividend
Apr 23, 03
08:45 ET	Perrigo Company Reports Third Quarter Fiscal 2003 Earnings of $0.20 Per Share
Apr 17, 03
15:35 ET	Perrigo Company Will Release Third Quarter Results for Fiscal 2003 on April 23, 2003
Mar 28, 03
14:28 ET	Perrigo Company to Present at Banc of America Securities Consumer Conference
Jan 27, 03
09:09 ET	Andrx and Perrigo Announce Agreement to Market Loratadine Products
08:59 ET	Perrigo Company Reports Second Quarter Fiscal 2003 Earnings Of $0.24 Per Share
Jan 24, 03
11:04 ET	Perrigo Company Appoints Two New Directors To Its Board
Jan 23, 03
14:17 ET	Perrigo Company Institutes Cash Dividend
Jan 22, 03
08:40 ET	Perrigo Company Will Release Second Quarter Results For Fiscal 2003 on January 27, 2003
Oct 29, 02
16:05 ET	Perrigo Company Announces Appointment of New Board Member
Oct 24, 02
08:33 ET	Perrigo Company Reports First Quarter Fiscal 2003 Earnings of $0.28 Per Share
Oct 21, 02
09:38 ET	Perrigo Company Will Release First Quarter Results for Fiscal 2003 on October 24, 2002
Oct 07, 02
12:31 ET	Perrigo Company to Present at McDonald Investments Consumer Conference
Aug 20, 02
08:03 ET	Perrigo Company Extends Share Repurchase Program
Aug 02, 02
09:16 ET	Perrigo Company Reports Fiscal 2002 Financial Results
Jul 30, 02
07:45 ET	Webcast Alert: Perrigo Company Announces 2002 Fourth Quarter And Year-End Earnings Webcast
Jul 17, 02
10:01 ET	Perrigo Company Extends Share Repurchase Program
Apr 25, 02
08:33 ET	Perrigo Company Reports Third Quarter Fiscal 2002 Earnings of $0.26 Per Share
Apr 23, 02
09:04 ET	Perrigo Company Will Release Third Quarter Fiscal 2002 Results on April 25, 2002
Apr 05, 02
08:10 ET	Perrigo Company to Present at Banc of America Securities Consumer Conference
Apr 04, 02
08:44 ET	Perrigo Company Becomes First Company Worldwide to Earn NSF Registration for Nutritional Supplement Manufacturing Facilities
Jan 23, 02
08:50 ET	Perrigo Company Reports Second Quarter Fiscal 2002 Earnings of $0.22 Per Share
Jan 21, 02
09:48 ET	Perrigo Company to Report Second Quarter Fiscal 2002 Results On January 23, 2002
Dec 04, 01
09:48 ET	Perrigo Company Receives FDA Approval To Manufacture and Market Two New Products
Oct 23, 01
08:27 ET	Perrigo Company Reports First Quarter Fiscal 2002 Earnings Up 24 Percent at $0.17 Per Share
Oct 19, 01
11:57 ET	Perrigo Company to Report Fiscal First Quarter 2002 Results on October 23
Oct 11, 01
09:16 ET	Perrigo Company Extends Share Repurchase Program
Aug 15, 01
18:24 ET	Perrigo Company Recalls Children's Pain Reliever Suspension Liquid
09:04 ET	Perrigo Company Announces Fourth Quarter and Year End Results
Aug 02, 01
16:56 ET	Perrigo Company Announces Preliminary Results for Fiscal 2001 Fourth Quarter
Jun 29, 01
07:58 ET	Perrigo Company Completes Acquisition of Wrafton Laboratories Ltd.
Jun 07, 01
16:02 ET	Perrigo Announces Approval to Market Ibuprofen and Pseudoephedrine Tablets
Jun 01, 01
09:08 ET	Perrigo Announces Approval to Market Famotidine Tablets
08:02 ET	Perrigo Company to Acquire U.K.-Based Wrafton Laboratories Ltd.
May 18, 01
10:27 ET	Perrigo Company to Present at UBS Warburg Global Specialty Pharmaceuticals Conference
May 01, 01
09:40 ET	Perrigo Company Reports Third Quarter Earnings of $0.14 Per Share
Apr 25, 01
15:57 ET	Perrigo Company to Report Fiscal Third Quarter 2001 Results on May 1
Mar 29, 01
15:04 ET	Perrigo Company to Present at Banc of America Securities Consumer Conference
Feb 15, 01
11:38 ET	Perrigo Appoints Matthew E. Morris Senior Vice President and Chief Information Officer
Feb 07, 01
15:06 ET	Perrigo Company Names C. Ted Borgel Vice President of Quality and Compliance
Jan 23, 01
09:09 ET	Perrigo Company Reports Results for Fiscal Year 2001's Second Quarter
Jan 19, 01
14:07 ET	Perrigo Company Announces Earnings Release Conference Call
Nov 13, 00
16:24 ET	Perrigo Company Announces $20 Million Share Repurchase Program
Nov 08, 00
08:28 ET	Perrigo Company Discontinuing the Marketing of Products Containing Phenylpropanolamine Hydrochloride (PPA)
Oct 25, 00
09:50 ET	Perrigo Company Reports First Quarter Fiscal 2001 Earnings of $0.14 Per Share
Aug 16, 00
09:17 ET	Perrigo Company Reports Fiscal 2000 and Fourth Quarter Results
Apr 27, 00
14:30 ET	Perrigo Company Announces Dismissal of Grow Group Litigation
Apr 25, 00
09:20 ET	Perrigo Company Reports Third Quarter Results
Apr 20, 00
10:08 ET	Perrigo Company Appoints David T. Gibbons President and Chief Executive Officer
Mar 02, 00
13:36 ET	Perrigo Company Receives Approval to Market Acetaminophen Extended Release Tablets
Feb 09, 00
09:03 ET	Perrigo Company Announces Improved Second Quarter Sales and Earnings
Jan 04, 00
16:03 ET	Perrigo Company Names Douglas R. Schrank Executive Vice President and Chief Financial Officer
12:38 ET	Perrigo Company Names Douglas R. Schrank Executive Vice President and Chief Financial Officer
Dec 10, 99
08:26 ET	Perrigo Company Announces Highlights of Annual Shareholders' Meeting; New Director Elected
Nov 09, 99
09:47 ET	Perrigo Company Reports Improved Operating Results For Fiscal 2000's First Quarter
Oct 19, 99
10:47 ET	Perrigo Company Names John Hendrickson Executive Vice President and Chief Operations Officer; Richard Hansen Retires as President and Chief Operating Officer
Aug 26, 99
09:34 ET	Perrigo Company Announces Fourth Quarter and Full-Year 1999 Results
Aug 25, 99
18:06 ET	Perrigo Company Completes Sale of Personal Care Business
Jul 19, 99
12:21 ET	Perrigo Company Enters Into an Agreement in Principle To Sell Personal Care Business
Jun 10, 99
16:45 ET	Perrigo Company Provides Update on Workforce Reduction
May 27, 99
11:26 ET	Perrigo Company to Recoup $8 Million in Legal Expenses; U.S. District Court Approves Dismissal of Derivative Lawsuit
May 11, 99
09:50 ET	Perrigo Company Reports Increase in Third Quarter Sales and Earnings
May 03, 99
14:41 ET	Perrigo Company Receives Approval to Market Two New Products
Apr 15, 99
08:32 ET	Perrigo Company Announces Cost Reduction Initiatives
Apr 08, 99
14:05 ET	Perrigo Company Announces Appeal in Class Action Suit Dismissed; Final Judgment Entered
Mar 04, 99
16:10 ET	Perrigo Receives FDA Approval for Pseudoephedrine Extended-Release Tablets
Feb 11, 99
10:19 ET	Perrigo Company Announces Second Quarter Results
Jan 04, 99
14:29 ET	Elan Receives FDA Approval for Nicotine Patch Perrigo to Market the Product
Nov 17, 98
09:09 ET	Perrigo Company Announces First Quarter Results
Nov 10, 98
18:15 ET	Perrigo Company Names Richard G. Hansen President and Chief Operating Officer
Oct 28, 98
17:25 ET	Perrigo Company Expects Significant Shortfall in First Quarter 1999 Results
Aug 31, 98
10:02 ET	Perrigo Company Reports Fourth Quarter And Fiscal 1998 Results
Aug 26, 98
16:25 ET	Perrigo Company Announces Dismissal of Class Action Suit
Jun 29, 98
08:25 ET	Perrigo Company Announces Intention to Divest Personal Care Business
Jun 23, 98
14:37 ET	Perrigo to Market Cimetidine Tablets Through Agreement with Novopharm
Jun 19, 98
13:54 ET	Perrigo Company Announces Favorable Decision in Grow Case
May 01, 98
09:14 ET	Perrigo Company Announces Third Quarter Sales and Earnings
Feb 03, 98
09:08 ET	Perrigo Company Announces Second Quarter Results
Nov 06, 97
14:43 ET	Perrigo Company Announces Election of New Board Member
Oct 29, 97
09:34 ET	Perrigo Company Announces Strong First Quarter Results, Net Income Up 23 Percent
Oct 02, 97
11:32 ET	Perrigo Company Acquires Majority Interest in Mexican Pharmaceutical Company - Quimica y Farmacia
Sep 26, 97
10:24 ET	Perrigo Announces Executive Appointments
Sep 10, 97
09:25 ET	Perrigo Receives FDA Tentative Approval For Children's Ibuprofen Oral Suspension
Aug 13, 97
10:10 ET	Perrigo Company Reports Strong Increase in Sales and Earnings For Fourth Quarter and Fiscal 1997
May 06, 97
10:43 ET	Perrigo Company Reports Increase in Sales and Earnings In Third Quarter and Announces Share Repurchase Program
Feb 14, 97
16:57 ET	Perrigo Company Announces Introduction of Internet Website
Feb 11, 97
09:12 ET	Perrigo Company Announces Strong Second Quarter Results
Nov 04, 96
10:42 ET	Perrigo Company Announces Election of New Board Member
Oct 29, 96
10:49 ET	Perrigo Company Announces First Quarter Results
09:11 ET	Perrigo Company Announces First Quarter Results
Oct 08, 96
09:14 ET	Perrigo Receives FDA Approval for Naproxen Sodium
Aug 14, 96
09:18 ET	Perrigo Company Announces Fourth Quarter and Year-End Results